|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Htg Molecular Diagnostics, Inc (HTGM) |
|
|
$0.28 0.00 (0.00%) as of 4:30 Fri 11/20
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
9,000,000 |
| Market
Cap: |
2.56(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.2849 - $0.2849 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile HTG Molecular Diagnostics is a commercial stage RNA platform-based life sciences company focused on developing medicine. Co.'s product and service solutions are based on its digital HTG EdgeSeq technology that enables RNA profiling using a small amount of biological sample, in liquid or solid forms. Co. markets proprietary molecular profiling panels targeting late stage drug development programs with potential breakthrough therapies, such as immuno-oncology. Co.'s marketed panels include: HTG EdgeSeq Oncology Biomarker Panel; HTG EdgeSeq Precision Immuno-Oncology Panel; HTG Lung Fusions Assay; HTG Autoimmune Panel; HTG EdgeSeq Immuno-Oncology Assay; and HTG Mouse mRNA Tumor Response Panel.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
888 |
888 |
| Total Sell Value |
$0 |
$0 |
$710 |
$710 |
| Total People Sold |
0 |
0 |
1 |
1 |
| Total Sell Transactions |
0 |
0 |
1 |
1 |
| End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Mcmeans Shaun D |
VP, Finance & Admin. & CFO |
• – – |
2015-12-10 |
4 |
A |
$4.78 |
$5,000 |
D/D |
1,046 |
9,532 |
|
- |
|
| Gordon Debra A |
V.P. and Chief Legal Counsel |
• – – |
2015-12-10 |
4 |
A |
$4.78 |
$5,000 |
D/D |
1,046 |
7,402 |
|
- |
|
| Johnson Tim B |
President & CEO |
• • – |
2015-12-10 |
4 |
A |
$4.78 |
$10,000 |
D/D |
2,092 |
28,810 |
|
- |
|
| Gordon Debra A |
V.P. and Chief Legal Counsel |
• – – |
2015-08-27 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
6,356 |
|
- |
|
| Lubniewski John L |
Chief Business Officer |
• – – |
2015-08-27 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
11,071 |
|
- |
|
| Mcmeans Shaun D |
VP, Finance & Admin. & CFO |
• – – |
2015-08-27 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
8,486 |
|
- |
|
| Johnson Tim B |
President & CEO |
• • – |
2015-08-27 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
26,718 |
|
- |
|
| Johnson Tim B |
President & CEO |
• • – |
2015-08-24 |
4 |
B |
$5.34 |
$5,341 |
D/D |
1,000 |
11,718 |
2.81 |
- |
|
| Gordon Debra A |
V.P. and Chief Legal Counsel |
• – – |
2015-08-24 |
4 |
B |
$5.16 |
$5,160 |
D/D |
1,000 |
1,356 |
2.74 |
- |
|
| Roche Patrick C. |
SVP Research & Development |
• – – |
2015-08-18 |
4 |
B |
$5.75 |
$37,435 |
D/D |
6,500 |
6,500 |
2.74 |
- |
|
| Johnson Tim B |
President & CEO |
• • – |
2015-08-12 |
4 |
B |
$7.31 |
$37,623 |
D/D |
5,000 |
10,718 |
2.81 |
- |
|
| Mcmeans Shaun D |
VP, Finance & Admin. & CFO |
• – – |
2015-08-12 |
4 |
B |
$7.50 |
$4,875 |
D/D |
650 |
3,486 |
2.66 |
- |
|
| Lubniewski John L |
Chief Business Officer |
• – – |
2015-08-11 |
4 |
B |
$7.50 |
$38,348 |
D/D |
5,000 |
8,571 |
2.74 |
- |
|
| Senour Lawrence D. |
10% Owner |
– – • |
2015-05-11 |
4 |
B |
$14.00 |
$2,342,802 |
D/D |
167,343 |
756,704 |
2.45 |
- |
|
| Senour Lawrence D. |
10% Owner |
– – • |
2015-05-11 |
4 |
A |
$0.00 |
$775,278 |
D/D |
108,306 |
589,361 |
|
- |
|
| Senour Lawrence D. |
10% Owner |
– – • |
2015-05-11 |
4 |
A |
$0.00 |
$0 |
D/D |
481,055 |
481,055 |
|
- |
|
| Lubniewski John L |
Chief Business Officer |
• – – |
2015-05-11 |
4 |
A |
$0.00 |
$0 |
D/D |
737 |
3,571 |
|
- |
|
| Lubniewski John L |
Chief Business Officer |
• – – |
2015-05-11 |
4 |
A |
$0.00 |
$0 |
D/D |
2,834 |
2,834 |
|
- |
|
| George Harry A. |
Director |
– • – |
2015-05-11 |
4 |
A |
$0.00 |
$0 |
I/I |
39,679 |
144,366 |
|
- |
|
| Glaxosmithkline Plc |
10% Owner |
– – • |
2015-05-11 |
4 |
A |
$0.00 |
$0 |
I/I |
592,866 |
1,049,243 |
|
- |
|
| Glaxosmithkline Plc |
10% Owner |
– – • |
2015-05-11 |
4 |
A |
$0.00 |
$0 |
I/I |
91,271 |
938,488 |
|
- |
|
| Glaxosmithkline Plc |
10% Owner |
– – • |
2015-05-11 |
4 |
B |
$14.00 |
$5,111,484 |
I/I |
365,106 |
365,106 |
1.5 |
- |
|
| Novo A/s |
10% Owner |
– – • |
2015-05-11 |
4 |
B |
$14.00 |
$5,111,484 |
D/D |
365,106 |
1,280,185 |
2.45 |
- |
|
| Novo A/s |
10% Owner |
– – • |
2015-05-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
49,786 |
915,079 |
|
- |
|
| Novo A/s |
10% Owner |
– – • |
2015-05-11 |
4 |
A |
$0.00 |
$0 |
D/D |
865,293 |
865,293 |
|
- |
|
227 Records found
|
|
Page 9 of 10 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
